Form 4 for TCRX TScan Therapeutics, Inc.
Accepted 2021-07-22 00:00:00 ET · period of report 2021-07-15 · accession 0000899243-21-029437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-22 | 2021-07-20 | TCRX | Silver Brian M. | CFO | P - Purchase | $15.00 | +1,000 | 1,000 | New | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2021-07-20 | P | A | 1,000 | $15.00 | 1,000 | D | — | — | (F1) Represents shares purchased in the Issuer's initial public offering. |